S

Shanghai Henlius Biotech Inc
HKEX:2696

Watchlist Manager
Shanghai Henlius Biotech Inc
HKEX:2696
Watchlist
Price: 20.25 HKD -0.25% Market Closed
Market Cap: 11B HKD
Have any thoughts about
Shanghai Henlius Biotech Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Shanghai Henlius Biotech Inc

Current Assets 2.4B
Cash & Short-Term Investments 649.4m
Receivables 908.8m
Other Current Assets 838.4m
Non-Current Assets 7.6B
PP&E 2.7B
Intangibles 4.8B
Other Non-Current Assets 46.4m
Current Liabilities 4.9B
Accounts Payable 617.1m
Other Current Liabilities 4.3B
Non-Current Liabilities 2.5B
Long-Term Debt 1.2B
Other Non-Current Liabilities 1.3B

Balance Sheet
Shanghai Henlius Biotech Inc

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
59
959
2 301
1 114
707
680
988
Cash
0
0
0
0
707
680
988
Cash Equivalents
59
959
2 301
1 114
0
0
0
Short-Term Investments
7
18
29
24
35
160
0
Total Receivables
117
58
148
402
429
508
865
Accounts Receivables
20
7
30
196
296
456
730
Other Receivables
97
52
119
206
133
52
135
Inventory
25
25
130
305
420
757
757
Other Current Assets
26
26
53
64
91
86
66
Total Current Assets
233
1 087
2 661
1 910
1 647
2 192
2 676
PP&E Net
459
495
857
1 437
1 667
2 230
2 653
PP&E Gross
459
495
857
1 437
1 667
2 230
2 653
Accumulated Depreciation
60
98
154
231
325
452
602
Intangible Assets
772
1 383
2 175
2 942
3 635
4 332
4 511
Other Long-Term Assets
21
130
207
150
224
171
64
Total Assets
1 485
N/A
3 095
+108%
5 900
+91%
6 439
+9%
7 173
+11%
8 924
+24%
9 904
+11%
Liabilities
Accounts Payable
74
85
240
299
383
714
545
Accrued Liabilities
34
73
134
267
418
854
1 059
Short-Term Debt
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
596
143
278
1 188
1 571
2 522
2 800
Other Current Liabilities
508
232
307
225
588
912
663
Total Current Liabilities
1 212
533
960
1 980
2 960
5 002
5 067
Long-Term Debt
163
385
331
645
1 052
1 155
1 293
Minority Interest
4
0
0
0
0
0
0
Other Liabilities
186
373
609
616
864
1 131
1 351
Total Liabilities
1 565
N/A
1 292
-17%
1 899
+47%
3 240
+71%
4 876
+50%
7 288
+49%
7 711
+6%
Equity
Common Stock
366
474
543
543
543
543
543
Retained Earnings
770
1 528
2 280
3 296
4 253
4 952
4 414
Additional Paid In Capital
327
2 857
5 738
5 954
6 010
6 052
6 069
Other Equity
3
1
1
3
3
7
7
Total Equity
80
N/A
1 803
N/A
4 000
+122%
3 199
-20%
2 297
-28%
1 636
-29%
2 192
+34%
Total Liabilities & Equity
1 485
N/A
3 095
+108%
5 900
+91%
6 439
+9%
7 173
+11%
8 924
+24%
9 904
+11%
Shares Outstanding
Common Shares Outstanding
366
474
543
543
543
543
543

See Also

Discover More